ZyVersa Therapeutics, Inc. (ZVSA) Dividend History

ZyVersa Therapeutics, Inc. (ZVSA) is a biotechnology company focused on developing therapies for inflammatory and immune-related diseases. The company is known for its research into innovative treatments that target underlying causes of chronic conditions, with an emphasis on creating novel formulations to improve patient outcomes.

217 W. Main Street, Somerville, NJ, 08876
Phone: 908-370-5102
Website: https://www.zyversa.com

Dividend History

ZyVersa Therapeutics, Inc. currently does not pay dividends

Company News

  • ZyVersa Therapeutics, a clinical-stage biopharmaceutical company, reported progress in its Phase 2a trial for Cholesterol Efflux Mediator™ VAR 200 in diabetic kidney disease and plans for its Inflammasome ASC Inhibitor IC 100 in obesity with metabolic complications. The company raised $0.8 million from warrant exercises and expects its current cash to fund operations on a month-to-month basis.

    GlobeNewswire Inc.
  • Shares of TransMedics Group, Inc. (NASDAQ: TMDX) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong guidance. The company posted quarterly earnings of 12 cents per share, compared to market estimates for a loss of 3 cents per share. The company’s quarterly sales came in at $81.17 million versus expectations of $68.51 million. TransMedics Group shares jumped 23.5% to $96.00 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Janux Therapeutics, Inc. (NASDAQ: JANX) gained 85.5% to $28.01 in pre-market trading after the company announced updated clinical data for both of its clinical programs. PubMatic, Inc. (NASDAQ: PUBM) shares rose 35.7% to $22.49 in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong guidance. Galera Therapeutics, Inc. (NASDAQ: GRTX) shares gained 37% to $0.2630 in pre-market trading. Galera Therapeutics 10% owner Yair Schneid acquired a total of 932,402 shares at an average price of $0.18. Infobird Co., Ltd (NASDAQ: IFBD) shares surged 36.2% to $3.76 in pre-market trading after dipping 27% on Monday. Infobird announced a Delay in ...

    Benzinga
    Featured Companies: ADN BSGM CARG GXAI HIMS IFBD JANX LUNR NRXP NYXH PUBM SRFM TMDX U
  • Are analyst ratings worth using to make money with penny stocks? The post Making Sense of Analyst Ratings With Penny Stocks appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: AVTX
Page data last updated 07/23/2025 09:30:34 UTC